CAS: 112-89-0; 1-Bromooctadecane

相似化合物

112-71-0 112-82-3 143-15-7

上下游产品

CAS号112-92-5 硬脂醇 | CAS号18748-98-6 硬脂氧基三甲基硅烷 | CAS号65598-06-3 triethyl(°Ctade... | CAS号65598-00-7 tert-butyl-dime... | CAS号20244-61-5 2,4,4,6-四溴-2,5-环己二烯酮 | CAS号66938-10-1 2-°Ctadecoxyoxane | CAS号67603-49-0 (2R)-2-(hexadec... | CAS号79392-43-1 2,2,2-三氟乙酸十八烷基酯 | CAS号31081-59-1 °CTADECYLMETHAN... | CAS号62008-64-4 thi°Carbonic ac... | CAS号107019-92-1 3-(4-°Ctadecoxy... | CAS号10585-86-1 (4S)-2,2-dimeth... | CAS号108225-24-7 1-°Ctadecoxy-3-... | CAS号557-61-9 1-二十八烷醇 | CAS号3700-67-2 双十八烷基二甲基溴化铵 | CAS号593-45-3 正十八烷 | CAS号4724-47-4 磷酸正十八酯 | CAS号4088-22-6 N,N-双十八烷基甲胺 | CAS号4105-95-7 4-十八烷氧基苯甲醛 | CAS号143785-69-7 3,4-di°Ctadecox...

硬脂醇置于三溴化磷体系中,用 乙醚 用作溶剂,化学反应 2.0H,以95%的收率获得硬脂基溴
参考文献:3,11-二甲基nonacosan-2-One 的简单且经济有效的合成,德国蟑螂的雌性信息素.
标题:3,11-二甲基nonacosan-2-One 的简单且经济有效的合成,德国蟑螂的雌性信息素.
摘要:描述了 3,11-二甲基nonacosan-2-One (1) 的方便合成.我们的策略涉及使用众所周知的 C-烷基化和乙酰乙酸乙酯合成反应作为关键步骤.我们预计该方法将被证明可用于 1 的大规模制备和二甲基二十碳烷酮的改性.
Doi:10.3390/11100751

专利信息

专利号:US-10730904-B2
优先权日:2012-11-14
标 题:Method for liquid-phase synthesis of nucleic acid
发明人：NONOGAWA MITSURU; NAGATA TOSHIAKI; SAITO HIDEKI; YASUMA TSUNEO
权利人:TAKEDA PHARMACEUTICALS CO
摘要:In this method, an oligonucleotide represented by formula (II) [wherein Y 1 , Q, Base, r and r′ are each as defined in claim 1 ] is prepared by using, as a synthesis unit, a novel nucleoside monomer compound represented by formula (I) [wherein X, R 1 , Y, Base, Z, Ar, R 2 , R 3 and n are each as defined in claim 1 ]. The novel nucleoside monomer compound is a nucleoside, the base moiety of which is substituted with an aromatic-hydrocarbon-ring-carbonyl or -thiocarbonyl group having at least one hydrophobic group. The method can dispense with column-chromatographic purification in every reaction, and enables base elongation not only in the 3′-direction but also in the 5′-direction, thus attaining efficient liquid-phase mass synthesis of an oligonucleotide.

专利号:US-6262251-B1
优先权日:1995-10-19
标题 :Method for solution phase synthesis of oligonucleotides
发明人：PIEKEN WOLFGANG; MCGEE DANNY; SETTLE ALECIA; ZHAI YANSHENG; HUANG JIANPING
权利人:PROLIGO LLC
摘要:This invention discloses an improved method for the sequential solution phase synthesis of oligonucleotides. The method lends itself to automation and is ideally suited for large scale manufacture of oligonucleotides with high efficiency.

专利号:EP-3480195-A1
优先权日:2017-11-07
标 题:Method for the synthesis of cyclic depsipeptides
权利人:BAYER ANIMAL HEALTH GMBH; THE KITASATO INST
摘要:The present invention relates to a method for the synthesis of cyclic depsipeptides, in particular emodepside, involving specific carboxylic acid group protecting tags: nTAG is preferably: nwherein m is ‰¥ 15 to ‰¤ 25, p is ‰¥ 8 to ‰¤ 18 and q is ‰¥ 15 to ‰¤ 25.

专利号:US-12122759-B2
优先权日:2017-11-07
标 题:Method for the synthesis of cyclic depsipeptides
发明人：HEIMBACH DIRK; OMURA SATOSHI; SUNAZUKA TOSHIAKI; HIROSE TOMOYASU; NOGUCHI YOSHIHIKO; Köbberling Johannes; WU ZHIJIE; FU SHUIBIAO; WU WEI; QIU JINFENG; HE LIU; WEI XUDONG
权利人:ELANCO ANIMAL HEALTH GMBH; THE KITASATO INST
摘要:The present invention relates to a method for the synthesis of cyclic depsipeptides, in particular emodepside, from the open form.

专利号:WO-9847910-A1
优先权日:1997-04-21
标题:Method for solution phase synthesis of oligonucleotides
发明人：PIEKEN WOLFGANG; MCGEE DANNY; SETTLE ALECIA; ZHAI YANSHENG; HUANG JIANPING; HILL KEN; SMITH RANDALL S
权利人:NEXSTAR PHARMACEUTICALS INC; PIEKEN WOLFGANG; MCGEE DANNY; SETTLE ALECIA; ZHAI YANSHENG; HUANG JIANPING; HILL KEN; SMITH RANDALL S
摘要:This invention discloses an improved method for the sequential solution phase synthesis of oligonucleotides. The method lends itself to automation and is ideally suited for large scale manufacture oligonucleotides with high efficiency.

专利号:US-5874532-A
优先权日:1997-01-08
标 题 :Method for solution phase synthesis of oligonucleotides and peptides
发明人：PIEKEN WOLFGANG; GOLD LARRY
权利人:NEXSTAR PHARMACEUTICALS INC
摘要:This invention discloses an improved method for the sequential solution phase synthesis of oligonucleotides and peptides. The method lends itself to automation and is ideally suited for large scale manufacture oligonucleotides with high efficiency.